Macrophage migration inhibitory factor polymorphism and the risk of ulcerative colitis and Crohn's disease in Asian and European populations: A meta-analysis

BMJ Open

Volumn 3, Issue 12, 2013, Pages

  Hao, Ning Bo ^a   He, Ya Fei ^a   Luo, Gang ^a   Yong, Xin ^a   Zhang, Yao ^a   Yang, Shi Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ARTICLE; ASIAN; CODOMINANCE; CROHN DISEASE; DATA SYNTHESIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ETHNICITY; EUROPEAN AMERICAN; GENETIC HETEROGENEITY; HUMAN; META ANALYSIS; PUBLICATION; PUBLISHING; QUANTITATIVE ANALYSIS; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; ULCERATIVE COLITIS;

EID: 84892579972     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003729     Document Type: Article

References (35)

1. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007;369:1627-40. (Pubitemid 46722636)
2. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterol 2004;126:1504-17. (Pubitemid 38649869)
3. van Lierop PP, Samsom JN, Escher JC, et al. Role of the innate immune system in the pathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2009;48:142-51.
4. Bacher M, Meinhardt A, Lan HY, et al. Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 1997;150:235-46. (Pubitemid 27027113)
5. Baugh JA, Bucala R. Macrophage migration inhibitory factor. Crit Care Med 2002;30:S27-35. (Pubitemid 34131159)
6. Rosado Jde D, Rodriguez-Sosa M. Macrophage migration inhibitory factor (MIF): a key player in protozoan infections. Int J Biol Sci 2011;7:1239-56.
7. Gregersen PK, Bucala R. Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis Rheum 2003;48:11716.
8. Morand EF, Bucala R, Leech M. Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis. Arthritis Rheum 2003;48:291-9. (Pubitemid 36277995)
9. Lan HY, Mu W, Yang N, et al. De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol 1996;149:1119-27. (Pubitemid 26337231)
10. Lan HY, Yang N, Nikolic-Paterson DJ, et al. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 2000;57:499-509. (Pubitemid 30430641)
11. de Jong YP, Abadia-Molina AC, Satoskar AR, et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2001;2:1061-6. (Pubitemid 33069502)
12. Renner P, Roger T, Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis 2005;41(Suppl 7):S513-19. (Pubitemid 41598313)
13. Donn RP, Shelley E, Ollier WE, et al. A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001;44:1782-5. (Pubitemid 32758224)
14. Baugh JA, Chitnis S, Donnelly SC, et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002;3:170-6. (Pubitemid 38961128)
15. Griga T, Wilkens C, Wirkus N, et al. A polymorphism in the macrophage migration inhibitory factor gene is involved in the genetic predisposition of Crohn's disease and associated with cumulative steroid doses. Hepatogastroenterol 2007;54:784-6. (Pubitemid 46903723)
16. Fei BY, Lv HX, Yang JM, et al. Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population. Cytokine 2008;41:44-7.
17. Oliver J, Marquez A, Gomez-Garcia M, et al. Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease. Gut 2007;56:150-1. (Pubitemid 46044902)
18. Little J, Bradley L, Bray MS, et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002;156:300-10. (Pubitemid 34857997)
19. Whiting PF, Weswood ME, Rutjes AW, et al. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006;6:9.
20. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
22. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. World J Gastroentero 1997;315:629-34. (Pubitemid 27387172)
23. Sivaram G, Tiwari SK, Bardia A, et al. Macrophage migration inhibitory factor, Toll-like receptor 4, and CD14 polymorphisms with altered expression levels in patients with ulcerative colitis. Hum Immunol 2012;73:201-5.
24. Przybylowska K, Mrowicki J, Sygut A, et al. Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases. Pol Przegl Chir 2011;83:76-80.
25. Shiroeda H, Tahara T, Nakamura M, et al. Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan. Cytokine 2010;51:173-7.
26. Nohara H, Okayama N, Inoue N, et al. Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 2004;39:242-6. (Pubitemid 38519429)
27. Paralkar V, Wistow G. Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 1994;19:48-51. (Pubitemid 24034365)
28. Budarf M, McDonald T, Sellinger B, et al. Localization of the human gene for macrophage migration inhibitory factor (MIF) to chromosome 22q11.2. Genomics 1997;39:235-6. (Pubitemid 27069223)
29. Donn R, Alourfi Z, De Benedetti F, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002;46:2402-9.
30. Yun J, Xu CT, Pan BR. Epidemiology and gene markers of ulcerative colitis in the Chinese. World J Gastroenterol 2009;15:788-803.
31. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603. (Pubitemid 32531408)
32. Ng SC, Tsoi KK, Kamm MA, et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis 2012;18:1164-76.
33. Zhang ZF, Yang N, Zhao G, et al. Association between the Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma 2 and inflammatory bowel disease: a meta-analysis. PLoS ONE 2012;7:e30551.
34. Shen Y, Guo S, Yang T, et al. The -173 G/C polymorphism of the MIF gene and inflammatory bowel disease risk: a meta-analysis. Int J Mol Sci 2013;14:11392-401.
35. Zhang H, Ma L, Dong LQ, et al. Association of the macrophage migration inhibitory factor gene-173G/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects. Gene 2013;526:228-31